Pharmaceuticals
GSK made the biggest climate promise in pharma. Can it keep it?
The company's path to its 2030 goals rests on dramatic reductions in two Scope 3 categories. Read More
The company's path to its 2030 goals rests on dramatic reductions in two Scope 3 categories. Read More